Table 1 Patient baseline and correlation between NCKAP1 expression and clinicopathologic characteristics in hepatocellular carcinoma (HCC)
NCKAP1 expression levels | ||||
|---|---|---|---|---|
Clinicopathological variable | No. | Negative | Positive | P value |
Age (yr) | Â | Â | Â | 0.559 |
≤50 | 101 | 57 | 44 |  |
>50 | 79 | 48 | 31 | Â |
Gender | Â | Â | Â | 0.305 |
Female | 19 | 9 | 10 | Â |
Male | 161 | 96 | 65 | Â |
Hepatitis B surface Ag | Â | Â | Â | 0.682 |
Negative | 15 | 8 | 7 | Â |
Positive | 165 | 97 | 68 | Â |
Serum AFP (ng/mL) | Â | Â | Â | 0.325 |
<400 | 93 | 51 | 42 | Â |
≥400 | 87 | 54 | 33 |  |
Tumor size (cm) | Â | Â | Â | 0.235 |
≤5 | 70 | 37 | 33 |  |
>5 | 110 | 68 | 42 | Â |
Tumor number | Â | Â | Â | 0.272 |
Solitary | 134 | 75 | 59 | Â |
Multiple | 46 | 30 | 16 | Â |
Microvascular invasion | Â | Â | Â | 0.217 |
No | 108 | 59 | 49 | Â |
Yes | 72 | 46 | 26 | Â |
PVTT | Â | Â | Â | 0.916 |
No | 153 | 89 | 64 | Â |
Yes | 27 | 16 | 11 | Â |
Liver cirrhosis | Â | Â | Â | 0.494 |
No | 48 | 30 | 18 | Â |
Yes | 132 | 75 | 57 | Â |
Differentiation grade | Â | Â | Â | 0.467 |
I + II | 112 | 63 | 49 |  |
III + IV | 68 | 42 | 26 |  |
BCLC stage | Â | Â | Â | 0.272 |
0–A | 134 | 75 | 59 |  |
B–C | 46 | 30 | 16 |  |
TNM stage | Â | Â | Â | 0.405 |
I | 87 | 48 | 39 | Â |
II–IV | 93 | 57 | 36 |  |